Zenas Biopharma Inc
(ZBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 5,000 | 50,000 | 0 |
| Gross Profit | 5,000 | 50,000 | N/A |
| Operating Expenses | 168,888 | 87,147 | 76,199 |
| Operating Income | -163,888 | -37,147 | -76,199 |
| Other Income | 7,329 | 324 | -43,083 |
| Pre-tax Income | -156,559 | -36,823 | -119,282 |
| Income Tax | 429 | 301 | N/A |
| Net Income Continuous | -156,988 | -37,124 | -119,282 |
| Net Income | $-156,988 | $-37,124 | $-119,282 |
| EPS Basic Total Ops | -11.89 | -24.25 | -79.94 |
| EPS Basic Continuous Ops | -11.89 | -24.25 | -79.95 |
| EPS Diluted Total Ops | -11.89 | -24.25 | -79.94 |
| EPS Diluted Continuous Ops | -11.89 | -24.25 | -79.95 |
| EBITDA(a) | $-163,751 | $-37,034 | $-76,121 |